- Home
- MSFT vs NVO Comparison
MSFT vs NVO Comparison
Compare MSFT & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSFT | NVO |
|---|---|---|
| Founded | 1975 | 1923 |
| Country | United States | Denmark |
| Employees | N/A | 69500 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1T | 197.4B |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | MSFT | NVO |
|---|---|---|
| Price | $365.07 | $47.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 36 | 11 |
| Target Price | ★ $573.11 | $51.00 |
| AVG Volume (30 Days) | ★ 31.2M | 11.7M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | 0.86% | ★ 3.19% |
| EPS Growth | ★ 15.59 | N/A |
| EPS | ★ 13.14 | N/A |
| Revenue | ★ $62,484,000,000.00 | N/A |
| Revenue This Year | $18.76 | N/A |
| Revenue Next Year | $15.73 | $3.70 |
| P/E Ratio | $28.50 | ★ $13.60 |
| Revenue Growth | ★ 6.93 | N/A |
| 52 Week Low | $356.28 | $35.12 |
| 52 Week High | $555.45 | $71.80 |
Technical Indicators
Market Signals| Indicator | MSFT | NVO |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 64.55 |
| Support Level | $356.28 | $45.62 |
| Resistance Level | $426.12 | $47.79 |
| Average True Range (ATR) | 10.41 | 1.39 |
| MACD | -4.78 | 0.40 |
| Stochastic Oscillator | 1.45 | 95.31 |
Price Performance
Historical ComparisonAbout MSFT Microsoft Corporation
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
About NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.